Notably, the biopsies predicted to be most sensitive to GWL inhibition were overrepresented in kidney chromophobes (KICH) and, possibly, in low-grade glioma (LGG) and uveal melanoma (UVM) cancers (Fig. 8f). This evidence concerns the gene MASTL and uveal melanoma.